Dietary fibre improves first-phase insulin secretion in overweight individuals

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Bodinham, Caroline L ^a   Smith, Leanne ^a   Wright, John ^a   Frost, Gary S ^b   Robertson, M Denise ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; INSULIN; RESISTANT STARCH; STARCH; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CARBOHYDRATE INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIETARY FIBER; FEMALE; FOOD INTAKE; HUMAN; INSULIN RELEASE; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; OBESITY; RANDOMIZED CONTROLLED TRIAL;

ADULT; BLOOD GLUCOSE; DIETARY FIBER; DIETARY SUPPLEMENTS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; OVERWEIGHT; PLACEBOS;

EID: 84864001545     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040834     Document Type: Article

References (21)

1. (2011) Standards of medical care in diabetes-2011. Diabetes Care 34: S11-61.
2. Gerich JE, (2002) Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes? Diabetes 51: S117-121.
3. Porte D, (1991) Banting lecture 1990. Beta-cells in type II diabetes mellitus. Diabetes 40: 166-180.
4. Hosker JP, Rudenski AS, Burnett MA, Matthews DR, Turner RC, (1989) Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy. Metabolism 38: 767-772.
5. Hosker JP, Burnett MA, Davies EG, Harris EA, Turner RC, (1985) Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients. Diabetologia 28: 809-814.
6. Bodinham CL, Frost GS, Robertson MD, (2010) Acute ingestion of resistant starch reduces food intake in healthy adults. Br J Nutr 103: 917-922.
7. Robertson MD, Bickerton AS, Dennis AL, Vidal H, Frayn KN, (2005) Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am J Clin Nutr 82: 559-567.
8. Robertson MD, Currie JM, Morgan LM, Jewell DP, Frayn KN, (2003) Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects. Diabetologia 46: 659-665.
9. Johnston KL, Thomas EL, Bell JD, Frost GS, Robertson MD, (2010) Resistant starch improves insulin sensitivity in metabolic syndrome. Diabet Med 27: 391-397.
10. Balkau B, Charles MA, (1999) Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16: 442-443.
11. Strazzullo P, Barbato A, Siani A, Cappuccio FP, Versiero M, et al. (2008) Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population. Metabolism 57: 355-361.
12. Boston RC, Stefanovski D, Moate PJ, Sumner AE, Watanabe RM, et al. (2003) MINMOD Millennium: A Computer Program to Calculate Glucose Effectiveness and Insulin Sensitivity from the Frequently Sampled Intravenous Glucose Tolerance Test. Diabetes Technology & Therapeutics 5: 1003-1015.
13. Juntunen KS, Laaksonen DE, Poutanen KS, Niskanen LK, Mykkanen HM, (2003) High-fiber rye bread and insulin secretion and sensitivity in healthy postmenopausal women. Am J Clin Nutr 77: 385-391.
14. Shen L, Keenan MJ, Raggio A, Williams C, Martin RJ, (2011) Dietary-resistant starch improves maternal glycemic control in Goto-Kakizaki rat. Mol Nutr Food Res 55: 1499-1508.
15. Keenan MJ, Zhou J, McCutcheon KL, Raggio AM, Bateman HG, et al. (2006) Effects of resistant starch, a non-digestible fermentable fiber, on reducing body fat. Obesity (Silver Spring) 14: 1523-1534.
16. Shen L, Keenan MJ, Martin RJ, Tulley RT, Raggio AM, et al. (2009) Dietary resistant starch increases hypothalamic POMC expression in rats. Obesity (Silver Spring) 17: 40-45.
17. Zhou J, Martin RJ, Tulley RT, Raggio AM, McCutcheon KL, et al. (2008) Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am J Physiol Endocrinol Metab 295: E1160-1166.
18. Freeland KR, Wilson C, Wolever TM, (2010) Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects. Br J Nutr 103: 82-90.
19. Al-Lahham SH, Peppelenbosch MP, Roelofsen H, Vonk RJ, Venema K, (2010) Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim Biophys Acta 1801: 1175-1183.
20. Campbell IW, (2005) The Clinical Significance of PPAR Gamma Agonism. Curr Mol Med 5: 349-363.
21. Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG, Alexandrides TK, (2003) Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes 52: 1098-1103.